P

Inventor

SHAO LIXIN

US34 patents
⚠️ This page may combine multiple inventors who share the name “SHAO LIXIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

INCYTE CORP

31 patents
US9334274B2May 10, 2016

N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors

INCYTE CORP57 citations97
US10640506B2May 5, 2020

Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidines derivatives as JAK inhibitors

INCYTE CORP19 citations94
US10442803B2Oct 15, 2019

Tricyclic heterocycles as bet protein inhibitors

INCYTE CORP17 citations94
US10138248B2Nov 27, 2018

Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines, substituted imidazo[1,2-b]pyridazines and substituted imidazo[1,2-a]pyrazines as PI3K-γ inhibitors

INCYTE CORP36 citations94
US9777003B2Oct 3, 2017

Tricyclic heterocycles as bet protein inhibitors

INCYTE CORP25 citations94
US9309246B2Apr 12, 2016

Tricyclic heterocycles as BET protein inhibitors

INCYTE CORP33 citations94
US9193733B2Nov 24, 2015

Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors

INCYTE CORP33 citations94
US10065963B2Sep 4, 2018

Heterocyclic compounds as PI3K-γ inhibitors

INCYTE CORP16 citations92
US11091484B2Aug 17, 2021

Tricyclic heterocycles as BET protein inhibitors

INCYTE CORP8 citations84
US10975088B2Apr 13, 2021

Imidazo[2,1-f][1,2,4]triazine compounds as pi3k-y inhibitors

INCYTE CORP6 citations84
US10738057B2Aug 11, 2020

Tertiary alcohols as PI3K-γ inhibitors

INCYTE CORP5 citations84
US10479795B2Nov 19, 2019

Substituted imidazo[2,1-f][1,2,4]triazines, substituted imidazo[1,2-a]pyridines and substituted imidazo[1,2-b]pyridazines as PI3K-gamma inhibitors

INCYTE CORP13 citations84
US10472368B2Nov 12, 2019

Heterocyclic compounds as PI3K-γ inhibitors

INCYTE CORP12 citations84
US11926630B2Mar 12, 2024

Tertiary alcohols as PI3K-γ inhibitors

INCYTE CORP2 citations73
US11926616B2Mar 12, 2024

Aminopyrazine diol compounds as PI3K-γ inhibitors

INCYTE CORP2 citations73
US11352340B2Jun 7, 2022

Pyridine and pyridimine compounds as PI3K-gamma inhibitors

INCYTE CORP3 citations73
US11225486B2Jan 18, 2022

Tertiary alcohols as PI3K-γ inhibitors

INCYTE CORP4 citations73
US11091491B2Aug 17, 2021

Heterocyclic compounds as PI3K-y inhibitors

INCYTE CORP4 citations73
US10669262B2Jun 2, 2020

Aminopyrazine diol compounds as PI3K-γ inhibitors

INCYTE CORP4 citations73
US11078204B2Aug 3, 2021

Heterocyclic derivatives as PI3K inhibitors

INCYTE CORP2 citations72
US11046658B2Jun 29, 2021

Aminopyrazine derivatives as PI3K-γ inhibitors

INCYTE CORP4 citations72
US11691971B2Jul 4, 2023

Naphthyridinone compounds as JAK2 V617F inhibitors

INCYTE CORP1 citations63
US12516065B2Jan 6, 2026

Tertiary alcohols as PI3K-γ inhibitors

INCYTE CORP0 citations62
US12421197B2Sep 23, 2025

Aminopyrazine derivatives as PI3K-γ inhibitors

INCYTE CORP0 citations62
US12365668B2Jul 22, 2025

Aminopyrazine diol compounds as PI3K-y inhibitors

INCYTE CORP0 citations62
US12030885B2Jul 9, 2024

Substituted imidazo[2,1-f][1,2,4]triazines as PI3K-gamma inhibitors

INCYTE CORP0 citations62
US12006320B2Jun 11, 2024

Heterocyclic derivatives as PI3K inhibitors

INCYTE CORP0 citations62
US11952367B2Apr 9, 2024

Pyridine and pyridimine compounds as PI3K-gamma inhibitors

INCYTE CORP0 citations62
US11773102B2Oct 3, 2023

Heterocyclic compounds as PI3K-γ inhibitors

INCYTE CORP0 citations62
US11958861B2Apr 16, 2024

Spirocyclic lactams as JAK2 V617F inhibitors

INCYTE CORP1 citations60
US11306079B2Apr 19, 2022

3-(5-amino-pyrazin-2-yl)-benzenesulfonamide derivatives and related compounds as PI3K-gamma kinase inhibitors

INCYTE CORP0 citations51

RODGERS JAMES D

2 patents

SYNOPSYS INC

1 patent